On 17 June 2026, Sino Biopharmaceutical Limited announced an updated list of directors and detailed their roles across five board committees. The Board now comprises five executive directors and six independent non-executive directors, with Ms. Theresa Y. Y. Tse serving as Chairwoman.

Executive Directors • Theresa Y. Y. Tse (Chairwoman) • Tse Ping (Senior Vice Chairman) • Cheng Cheung Ling (Vice Chairwoman) • Eric S. Y. Tse (Chief Executive Officer) • Tse Hsin

Independent Non-executive Directors • Lu Zhengfei • Lu Hong • Zhang Lu Fu • Dr. Li Kwok Tung Donald • Dr. Chen Lieping • Dr. Lu Bai

Committee Leadership and Membership • Executive Board Committee: Chaired by Theresa Y. Y. Tse • Audit Committee: Chaired by Lu Zhengfei • Remuneration Committee: Chaired by Zhang Lu Fu • Nomination Committee: Chaired by Cheng Cheung Ling • Environmental, Social and Governance Committee: Chaired by Theresa Y. Y. Tse

Each director’s committee memberships were also disclosed, underscoring the company’s emphasis on governance transparency and oversight.